期刊文献+

miR-26a对人肝癌HepG2蛋白表达的影响

The effect of miR-26a on the expression of protein in human hepatocarcinoma cell HepG2
下载PDF
导出
摘要 目的分析mircoRNA-26a(miR-26a)转染对人肝癌HepG2细胞表达蛋白质组的影响,以确定miR-26a与肝癌发生发展的相关性。方法常规培养人肝癌HepG2细胞株,经miR-26a转染72 h后裂解并提取蛋白,双向电泳分离,匹配对比各蛋白斑点的表达量,筛选主要差异表达蛋白进行质谱鉴定。结果 HepG2细胞经miR-26a转染后表达蛋白谱呈现普遍下调的趋势,差异表达超过2倍及以上的蛋白斑点有10个。其中,有3个蛋白斑点为表达上调,有7个蛋白斑点为表达下调。质谱鉴定为:膜联蛋白A1、过氧化物酶4、增殖细胞核抗原、载脂蛋白A1、细胞色素C氧化酶5a、磷酸核糖焦磷酸激酶3、周期素依赖性蛋白激酶1和磷脂酰乙醇胺结合蛋白。结论 miR-26a可能通过调节HepG2肝癌细胞上述蛋白分子的表达,直接或间接发挥其抑癌作用。通过对这些差异表达蛋白分子机制的深入研究,将为阐明miR-26a的抗癌作用提供进一步的线索和依据。 【Objective】 To determine the effect of microRNA-26a(miR-26a) transfection on proteomic expression profile in human hepatocarcinoma cell HepG2.【Methods】 HepG2 cells were transfected with miR-26a mimics or negative control for 72h.The proteins of HepG2 cells with or without miR-26a mimic treatment were extracted following the lysis of cells and extraction of proteins,and the extracted protein was separated by two-dimensional electrophoresis.The proteomic expression profiles were analyzed by comparative proteomics technique to discover important protein spots with different expressions,and the protein with different expression with miR-26a was identified by MALDI-TOF-MS.【Results】 The proteomic expression profile of HepG2 cells with miR-26a mimics treatment showed a general down-regulation.Total of ten protein spots with over 2 times change were successfully identified,including 3 up-regulated protein(annexin A1,peroxiredoxin 4 and apolipoprotein A1) and 6 down-regulated protein(proliferating cell nuclear antigen,cytochrome c oxidase subunit 5A,ribose-phosphate pyrophosphokinase 3,cyclin-dependent kinase 1,phosphatidylethanolamine-binding protein 1 and one unknown protein).【Conclusion】 MiR-26a could contribute its anti-cancer by regulating the expression of these proteins described above.Further investigation for the role of these proteins on pathogenesis of hepatocellular carcinoma is necessary.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2012年第19期1-5,共5页 China Journal of Modern Medicine
基金 四川省教育厅重点基金项目(No:09ZA050) 四川省卫生厅科技基金资助项目(No:2007-431)
关键词 miR-26a 人肝癌HepG2细胞株 蛋白表达 miR-26a human hepatocarcinoma cell HepG2 protein expression
  • 相关文献

参考文献2

二级参考文献10

  • 1程明亮.细胞信号转导与功能蛋白质组学在肝纤维化发生机制研究中的新动向[J].中西医结合肝病杂志,2005,15(4):193-194. 被引量:5
  • 2Staudenmarm W, Hatt PD, Hoving S, et al. Sample handling for proteome analysis. Electrophoresi, 1998,19:901-908.
  • 3Nabetani T, Tabuse Y, Tsugita A, et al. Proteomic analysis of livers of patients with primary hepatolithiasis. Proteomics ,2005,5: 1043-1061.
  • 4Gorg A, Obermaier C, Boguth G, et al. The current state of two dimensional electrophoresis with immobilized pH gradients. Electrophoresis,2000,21 : 1037-1053.
  • 5Xiao B, Smerdon SJ, Jones DH, et al. Structure of a 14-3-3 protein and implications for coordination of multiple signaling pathways. Nature,1995, 376: 188-191.
  • 6Gurusamy N, Watanabe K, Ma M, et al. Inactivation of 14-3-3 protein exacerbates cardiac hypertrophy and fibrosis through enhanced expression of protein kinase C beta 2 in experimental diabetes. Biol Pharm Bull, 2005,28:957-962.
  • 7Bandopadhyay R, Kingsbury AE, Cookson MR, et al. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. Brain, 2004, 127 : 420 - 430.
  • 8Hengst U, Albrecht H, Hess D, et al. The phosphatidylethanolamine-binding protein is the prototype of a novel family of serine protease inhibitors. J Biol Chem, 2001, 276:535-540.
  • 9Yamazaki T, Nakano H, Hayakariet M, et al. Differentiation induction of human keratinocytes by phosphatidylethanolamine-binding protein. J Biol Chem, 2004,279:32191-32195.
  • 10范德刚,范清宇,张惠中,张鹏,龙华,刘云燕,文艳华.联合运用基因芯片和反义寡核苷酸技术筛选骨肉瘤转移相关基因[J].中国现代医学杂志,2004,14(1):64-68. 被引量:6

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部